Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
doi: 10.1016/J.BONE.2019.115197 121 FemminellaGDFrangouELoveSBBuszaGHolmesCRitchieCet al
Clinical trials show significant weight regain occurs without continued treatment or alternative management strategies
Are already on TRT but still carry excess weight and struggle with metabolic health
With commercial insurance and the Novo Nordisk savings card, eligible patients may pay as little as $10-$25 per month
Ozempic (semaglutide), a GLP-1 receptor agonist licensed for type 2 diabetes treatment in the UK, lists dizziness as an uncommon side effect in the MHRA-approved Summary of Product Characteristics
US$ 23.64
US$ 27.59
US$ 23.73
US$ 21.38
US$ 26.80
